Latest News

Welltower Inc. recently closed an amended US$6.25 billion senior unsecured revolving credit facility, extending maturities to 2029–2030, modestly reducing pricing, and using cash on hand to repay its prior US$1.00 billion and C$250.00 million term loans while increasing total available credit facilities to about US$7.50 billion. By improving its credit outlook, lowering its borrowing spread to 67.5 basis points over SOFR, and adding the option to further upsize the facility, Welltower has...

Pfizer, NYSE:PFE, has secured multi year exemptions from proposed 100% US tariffs on imported patented medicines. In return, the company has agreed to invest $70b in US based R&D and manufacturing over several years. The agreement also includes regulatory grace periods, while many peers face disruption from the pending tariff regime. Pfizer shares trade at $27.16, with the stock up 7.9% year to date and 12.1% over the past year, although the 3 year return is an 18.4% decline. This mix of...

If you are wondering whether Equinix is priced attractively or already reflects a lot of optimism, you are in the right place to unpack what the current share price might be implying. At a recent close of US$956.07, Equinix has posted a 12.7% return over the last 30 days, 25.1% year to date, and 17.0% over the past year, with a 47.3% return over 3 years and 57.0% over 5 years, despite a 1.6% decline in the last week. Recent attention on Equinix has been driven more by its role in digital...

Yalla Group (YALA) has rounded out FY 2025 with fourth quarter revenue of about US$83.9 million and basic EPS of US$0.23, against a trailing twelve month EPS of US$0.96 that sits alongside earnings growth of 10.4% year on year. Over the past six quarters in the dataset, revenue has moved within a tight band between roughly US$83.9 million and US$90.8 million per quarter, while quarterly EPS has ranged from about US$0.20 to US$0.27, feeding into a trailing net profit margin of 43.8% that is...

SES (BDL:SESGL) is back in focus after reporting 2025 results alongside a proposed dividend, fresh 2026 guidance and a new satellite enabled agriculture project in South Africa that highlights its data-connectivity capabilities. See our latest analysis for SES. At a share price of €6.45, SES has had a mixed few weeks, with a 1 month share price return of 3.44% decline, a 90 day share price return of 19.44% and a 1 year total shareholder return of 23.32%. This suggests that recent earnings...

Elopak (OB:ELO) has launched a share buy-back programme of up to 600,000 shares to meet obligations under its long-term incentive plan, putting capital allocation and ownership structure in clearer focus for investors. See our latest analysis for Elopak. That buy-back announcement lands after a steady run in the share price, with a 6.7% 3 month share price return and a 41.7% 1 year total shareholder return. This suggests momentum has been building despite a slightly negative year to date...

FUJIFILM Holdings (TSE:4901) is back in focus after VolitionRx completed validation of an automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems in Japan, expanding automated canine cancer screening capacity across its laboratory network. See our latest analysis for FUJIFILM Holdings. The ¥3,017 share price comes after a mixed run, with a 1 day share price return of 1.67% set against a 90 day share price decline of 10.32% and a 1 year total shareholder return of 1.20%. Recent momentum looks...

L'Oréal (ENXTPA:OR) has drawn fresh attention from investors after announcing a multi year partnership with clean tech firm Dioxycle to turn captured carbon emissions into sustainable packaging materials via carbon electrolysis. See our latest analysis for L'Oréal. Despite a steady stream of sustainability, retail and product launches, L'Oréal's 30 day share price return of a 7.87% decline and modest 1 year total shareholder return of 3.76% suggest momentum has cooled recently compared with...

Syensqo SA has recently reported weaker fourth-quarter and full-year 2025 results, announced an annual dividend of €1.1340 per share for payment on 18 May 2026, redeemed €500,000,000 of 2.750% fixed-rate bonds early, and confirmed several Board changes including appointing Heike van de Kerkhof as independent Chair. These moves combine pressure on profitability with balance sheet reshaping and refreshed governance, giving investors a complex mix of cost, capital allocation and oversight...

Kering (ENXTPA:KER) has announced a wide reorganization, creating new Industry and Client centers of excellence and installing seasoned leaders to oversee production, supply chains, marketing, and client focused functions across its luxury Houses. See our latest analysis for Kering. At a share price of €262.65, Kering has seen a 3.1% 1 day and 3.3% 7 day share price return, yet its year to date share price return of 13.77% decline and 3 year total shareholder return of 49.01% decline suggest...

Why Van Lanschot Kempen’s latest earnings and dividend matter for shareholders Van Lanschot Kempen (ENXTAM:VLK) reported full year 2025 earnings alongside a fresh dividend announcement. This combination gives you new information on both the bank’s profitability profile and its approach to returning cash to shareholders. See our latest analysis for Van Lanschot Kempen. Investors appear to be reacting to the earnings and dividend news, with a 1-day share price return of 3.96% at a latest price...

If you are wondering whether Applied Materials' current share price still offers value after a big run, this article walks through how its valuation stacks up using several common methods. The stock recently closed at US$345.88, with returns of 7.2% over the past 30 days, 28.6% year to date, and 137.4% over the last year, which has reshaped how many investors think about its risk and return profile. Recent news around the broader semiconductor and AI supply chain has kept Applied Materials...

General Mills (GIS) stock is back in focus after Q2 2026 results highlighted about 25% growth in new product innovation, market share gains in 8 of its top 10 categories, and management’s more confident second half outlook. See our latest analysis for General Mills. Despite the Q2 2026 update and recent product news around K 12 reformulations and entertainment tie ins, momentum in the shares has been weak. A 30 day share price return of 11.68% and a 1 year total shareholder return of 28.77%...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has drawn fresh attention after reporting its 2025 results, announcing a €24.00 per share annual dividend and unveiling a share repurchase program of up to €2.25b. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. At a share price of €529.8, the stock has seen a 1-day share price return of 1.22% alongside a modest 7-day share price return of 0.99%. Its 1-year total shareholder return of a 2.28%...

CES Energy Solutions (TSX:CEU) is back in focus after reporting record 2025 results, featuring higher sales, net income, and earnings per share, along with a 29% increase to its quarterly dividend. See our latest analysis for CES Energy Solutions. The earnings announcement and dividend increase have arrived alongside strong price momentum, with a 37.11% 90 day share price return and a 164.53% 1 year total shareholder return suggesting growing investor interest rather than fading...

GE HealthCare Technologies (GEHC) just secured FDA 510(k) clearance for View, its cloud-native diagnostic viewer within the Genesis Radiology Workspace. This regulatory milestone could influence how investors think about the stock. See our latest analysis for GE HealthCare Technologies. Despite the FDA clearance for View and a steady stream of product news and conference appearances in early March, GE HealthCare’s share price has been under pressure, with a 30 day share price return of 9.82%...

Why CG Oncology Is On Investors’ Radar CG Oncology (CGON) has been drawing attention after a strong run in recent months, with the stock showing double digit gains over the past month and past 3 months. See our latest analysis for CG Oncology. With the share price at $62.80, CG Oncology has seen a 24.7% 1 month share price return and a 50.3% year to date share price return, while the 1 year total shareholder return stands at 138.8%, pointing to strong momentum over both shorter and longer...

If you are wondering whether Mastercard is priced fairly or if the recent weakness has opened a window of opportunity, this breakdown will help you see what the current share price actually implies. After a strong multi year run, with a 48.5% return over 3 years and 38.5% over 5 years, the stock is currently below its recent levels, with a 1.8% decline over 7 days, 6.2% over 30 days and 8.6% year to date, leaving it 1.5% lower over the past year. Recent attention on Mastercard has focused on...

If you are wondering whether ASML Holding's lofty share price still makes sense, you are not alone. This article focuses squarely on what you might be paying for and what you are getting in return. ASML's shares last closed at US$1,383.40, with returns of 1.7% over 7 days, a 2.1% decline over 30 days, 18.9% year to date, 101.9% over 1 year and 128.1% over 3 years. These figures raise fair questions about how much optimism is already reflected in the price. Recent attention on ASML has...

If you are wondering whether Paramount Skydance's current share price reflects its true worth, you are not alone. This article will walk through what the numbers say about its value. The stock last closed at US$10.33, with returns of a 17% decline over 7 days, a 2.2% decline over 30 days, a 21.6% decline year to date, an 8.6% decline over 1 year, a 44.4% decline over 3 years, and an 88.0% decline over 5 years. These moves may have reshaped how investors see its potential and risk. Recent...

Feathery has launched what it calls the first one click Schwab account API, allowing advisory firms to open NYSE:SCHW accounts directly from their own onboarding workflows. The integration is designed to cut manual data entry, reduce errors, and speed up client onboarding for advisors using Schwab as their custodian. The release also includes expanded onboarding capabilities that aim to standardize and automate more of the account opening process across advisory firms. For a firm like...

On 9 March 2026, Aon plc announced completing the first known stablecoin insurance premium payments among major global brokers, working with clients Coinbase and Paxos to settle premiums in trusted U.S. dollar-backed stablecoins across multiple blockchains, including USDC on Ethereum and PayPal USD on Solana. This move highlights Coinbase’s expanding role as compliant infrastructure for institutional use of stablecoins in traditional financial services, potentially deepening its ties with...

Kronos Worldwide (KRO) closed out FY 2025 with Q4 revenue of US$418.3 million and a basic EPS loss of US$0.72, capping off a trailing twelve month period where revenue totaled US$1.9 billion and basic EPS came in at a loss of US$0.96. Over recent quarters, the company has seen revenue move from US$423.1 million and basic EPS of a US$0.11 loss in Q4 2024 to US$489.8 million with EPS of US$0.16 in Q1 2025, before stepping down to US$456.9 million and a US$0.32 loss in Q3 2025 and ending at...

Why Hikari Tsushin’s New Bond Matters for Equity Investors Hikari Tsushin (TSE:9435) has launched an unsecured fixed income offering worth ¥91b, issuing 2.52% notes priced at 100% and maturing on March 12, 2030, a sizeable funding step for the group. This new bond gives you a fresh reference point on the company’s funding costs, balance sheet flexibility, and how management currently prefers to raise capital compared with equity or shorter term borrowing. See our latest analysis for Hikari...